"...Now there are tests for several physical indicators of Alzheimer’s, called biomarkers, that can reveal whether there are the telltale toxic proteins of beta-amyloid and tau in the brain. When combined with other information, these results can provide a relatively definitive diagnosis of early-stage Alzheimer’s disease and enable the person to make lifestyle changes, as well as start new treatments or clinical trials right away to attempt to alter its course."